Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?
Kurreck, Annika, Stintzing, Sebastian, Modest, Dominik P
Published in Journal of clinical oncology (10.04.2022)
Published in Journal of clinical oncology (10.04.2022)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
Stintzing, Sebastian, Dr, Modest, Dominik P, MD, Rossius, Lisa, Lerch, Markus M, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, MD, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, MD, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, MD, Stauch, Martina, MD, Scheithauer, Werner, Prof, Held, Swantje, MSc, Giessen-Jung, Clemens, MD, Moehler, Markus, Prof, Jagenburg, Andreas, MD, Kirchner, Thomas, Prof, Jung, Andreas, Prof, Heinemann, Volker, Prof
Published in The lancet oncology (01.10.2016)
Published in The lancet oncology (01.10.2016)
Get full text
Journal Article
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Prager, Gerald W., Taieb, Julien, Fakih, Marwan, Ciardiello, Fortunato, Van Cutsem, Eric, Elez, Elena, Cruz, Felipe M., Wyrwicz, Lucjan, Stroyakovskiy, Daniil, Pápai, Zsuzsanna, Poureau, Pierre-Guillaume, Liposits, Gabor, Cremolini, Chiara, Bondarenko, Igor, Modest, Dominik P., Benhadji, Karim A., Amellal, Nadia, Leger, Catherine, Vidot, Loïck, Tabernero, Josep
Published in The New England journal of medicine (04.05.2023)
Published in The New England journal of medicine (04.05.2023)
Get full text
Journal Article
Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)
Heinemann, Volker, Stintzing, Sebastian, Modest, Dominik P, Giessen-Jung, Clemens, Michl, Marlies, Mansmann, Ulrich R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)
Modest, Dominik P., Martens, Uwe M., Riera-Knorrenschild, Jorge, Greeve, Jobst, Florschütz, Axel, Wessendorf, Swen, Ettrich, Thomas, Kanzler, Stephan, Nörenberg, Dominik, Ricke, Jens, Seidensticker, Max, Held, Swantje, Buechner-Steudel, Petra, Atzpodien, Jens, Heinemann, Volker, Seufferlein, Thomas, Tannapfel, Andrea, Reinacher-Schick, Anke C., Geissler, Michael
Published in Journal of clinical oncology (10.12.2019)
Published in Journal of clinical oncology (10.12.2019)
Get full text
Journal Article
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives
Folprecht, Gunnar, Martinelli, Erika, Mazard, Thibault, Modest, Dominik P., Tsuji, Akihito, Esser, Regina, Cremolini, Chiara, Falcone, Alfredo
Published in Cancer treatment reviews (01.01.2022)
Published in Cancer treatment reviews (01.01.2022)
Get full text
Journal Article
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
Fakih, Marwan G, Salvatore, Lisa, Esaki, Taito, Modest, Dominik P, Lopez-Bravo, David P, Taieb, Julien, Karamouzis, Michalis V, Ruiz-Garcia, Erika, Kim, Tae-Won, Kuboki, Yasutoshi, Meriggi, Fausto, Cunningham, David, Yeh, Kun-Huei, Chan, Emily, Chao, Joseph, Saportas, Yaneth, Tran, Qui, Cremolini, Chiara, Pietrantonio, Filippo
Published in The New England journal of medicine (07.12.2023)
Published in The New England journal of medicine (07.12.2023)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Heinemann, Volker, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, Prof, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, Prof, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, Prof, Stauch, Martina, MD, Scheithauer, Werner, Prof, Hielscher, Jörg, Scholz, Michael, MD, Müller, Sebastian, MD, Link, Hartmut, Prof, Niederle, Norbert, Prof, Rost, Andreas, MD, Höffkes, Heinz-Gert, Prof, Moehler, Markus, Prof, Lindig, Reinhard U, MD, Modest, Dominik P, MD, Rossius, Lisa, MD, Kirchner, Thomas, Prof, Jung, Andreas, PhD, Stintzing, Sebastian, MD
Published in The lancet oncology (01.09.2014)
Published in The lancet oncology (01.09.2014)
Get full text
Journal Article
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial
Arends, Christopher Maximilian, Dimitriou, Savvina, Stahler, Arndt, Hablesreiter, Raphael, Strzelecka, Paulina M., Stein, Catarina M., Tilgner, Marlon, Saiki, Ryunosuke, Ogawa, Seishi, Bullinger, Lars, Modest, Dominik P., Stintzing, Sebastian, Heinemann, Volker, Damm, Frederik
Published in Blood (10.03.2022)
Published in Blood (10.03.2022)
Get full text
Journal Article
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial
Einem, Jobst Christian, Guenther, Christine, Volk, Hans‐Dieter, Grütz, Gerald, Hirsch, Daniela, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno, Heinemann, Volker
Published in International journal of cancer (15.09.2019)
Published in International journal of cancer (15.09.2019)
Get full text
Journal Article
Impact of Subsequent Therapies on Outcome of the FIRE-3/AIO KRK0306 Trial: First-Line Therapy With FOLFIRI Plus Cetuximab or Bevacizumab in Patients With KRAS Wild-Type Tumors in Metastatic Colorectal Cancer
Modest, Dominik P, Stintzing, Sebastian, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Vehling-Kaiser, Ursula, Al-Batran, Salah-Eddin, Heintges, Tobias, Lerchenmüller, Christian, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Stauch, Martina, Scheithauer, Werner, Held, Svantje, Möhler, Markus, Jung, Andreas, Kirchner, Thomas, Heinemann, Volker
Published in Journal of clinical oncology (10.11.2015)
Published in Journal of clinical oncology (10.11.2015)
Get full text
Journal Article
Correction: Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A systematic literature review
Raschzok, Nathanael, Moosburner, Simon, Blank, Moritz, Krenzien, Felix, Lurje, Georg, Schöning, Wenzel, Sauer, Igor M, Pratschke, Johann, Modest, Dominik P, Kurreck, Annika
Published in BMC cancer (11.11.2024)
Published in BMC cancer (11.11.2024)
Get full text
Journal Article
Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A systematic literature review
Raschzok, Nathanael, Moosburner, Simon, Blank, Moritz, Krenzien, Felix, Lurje, Georg, Schöning, Wenzel, Sauer, Igor M, Pratschke, Johann, Modest, Dominik P, Kurreck, Annika
Published in BMC cancer (10.10.2024)
Published in BMC cancer (10.10.2024)
Get full text
Journal Article
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
Haas, Michael, Heinemann, Volker, Kullmann, Frank, Laubender, Rüdiger P., Klose, Christina, Bruns, Christiane J., Holdenrieder, Stefan, Modest, Dominik P., Schulz, Christoph, Boeck, Stefan
Published in Journal of cancer research and clinical oncology (01.04.2013)
Published in Journal of cancer research and clinical oncology (01.04.2013)
Get full text
Journal Article
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
Kehmann, Linde, Berres, Marie-Luise, Gonzalez-Carmona, Maria, Modest, Dominik P, Mohr, Raphael, Wree, Alexander, Venerito, Marino, Strassburg, Christian, Keitel, Verena, Trautwein, Christian, Luedde, Tom, Roderburg, Christoph
Published in BMC cancer (22.05.2023)
Published in BMC cancer (22.05.2023)
Get full text
Journal Article
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer
Ohnmacht, Alexander J., Stahler, Arndt, Stintzing, Sebastian, Modest, Dominik P., Holch, Julian W., Westphalen, C. Benedikt, Hölzel, Linus, Schübel, Marisa K., Galhoz, Ana, Farnoud, Ali, Ud-Dean, Minhaz, Vehling-Kaiser, Ursula, Decker, Thomas, Moehler, Markus, Heinig, Matthias, Heinemann, Volker, Menden, Michael P.
Published in Nature communications (04.09.2023)
Published in Nature communications (04.09.2023)
Get full text
Journal Article
NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?—Case series and review of the literature
Osumi, Hiroki, Vecchione, Loredana, Keilholz, Ulrich, Vollbrecht, Claudia, Alig, Annabel H.S., von Einem, Jobst C., Stahler, Arndt, Striefler, Jana K., Kurreck, Annika, Kind, Andreas, Modest, Dominik P., Stintzing, Sebastian, Jelas, Ivan
Published in European journal of cancer (1990) (01.08.2021)
Published in European journal of cancer (1990) (01.08.2021)
Get full text
Journal Article
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer
Boeck, Stefan, Jung, Andreas, Laubender, Rüdiger P., Neumann, Jens, Egg, Rosalind, Goritschan, Clara, Ormanns, Steffen, Haas, Michael, Modest, Dominik P., Kirchner, Thomas, Heinemann, Volker
Published in Journal of gastroenterology (01.04.2013)
Published in Journal of gastroenterology (01.04.2013)
Get full text
Journal Article
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
Raimondi, Alessandra, Nichetti, Federico, Stahler, Arndt, Wasan, Harpreet S., Aranda, Enrique, Randon, Giovanni, Kurreck, Annika, Meade, Angela M., Díaz-Rubio, Eduardo, Niger, Monica, Stintzing, Sebastian, Palermo, Federica, Trarbach, Tanja, Prisciandaro, Michele, Sommerhäuser, Greta, Fisher, David, Morano, Federica, Pietrantonio, Filippo, Modest, Dominik P.
Published in European journal of cancer (1990) (01.09.2023)
Published in European journal of cancer (1990) (01.09.2023)
Get full text
Journal Article
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)
Stahler, Arndt, Kind, Andreas J, Sers, Christine, Mamlouk, Soulafa, Müller, Lothar, Karthaus, Meinolf, Fruehauf, Stefan, Graeven, Ullrich, Fischer von Weikersthal, Ludwig, Sommerhäuser, Greta, Kasper, Stefan, Hoppe, Beeke, Kurreck, Annika, Held, Swantje, Heinemann, Volker, Horst, David, Jarosch, Armin, Stintzing, Sebastian, Trarbach, Tanja, Modest, Dominik P
Published in Clinical cancer research (01.04.2024)
Published in Clinical cancer research (01.04.2024)
Get full text
Journal Article